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Intellectual disabilityAlterations in cerebral cortex connectivity lead to intellectual disability and in Down syndrome, this is associated
with a deﬁcit in cortical neurons that arises during prenatal development. However, the pathogenicmechanisms
that cause this deﬁcit have not yet been deﬁned. Here we show that the human DYRK1A kinase on chromosome
21 tightly regulates the nuclear levels of Cyclin D1 in embryonic cortical stem (radial glia) cells, and that amodest
increase inDYRK1Aprotein in transgenic embryos lengthens theG1phase in these progenitors. These alterations
promote asymmetric proliferative divisions at the expense of neurogenic divisions, producing a deﬁcit in cortical
projection neurons that persists in postnatal stages. Moreover, radial glial progenitors in the Ts65Dn mouse
model of Down syndrome have less Cyclin D1, and Dyrk1a is the triplicated gene that causes both early cortical
neurogenic defects and decreased nuclear Cyclin D1 levels in this model. These data provide insights into the
mechanisms that couple cell cycle regulation and neuron production in cortical neural stem cells, emphasizing
that the deleterious effect of DYRK1A triplication in the formation of the cerebral cortex begins at the onset of
neurogenesis, which is relevant to the search for early therapeutic interventions in Down syndrome.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The mammalian neocortex is the brain region responsible for
cognitive function, sensory perception and consciousness. It is formed
by many types of neurons and glial cells, all of which are distributed
across six histologically deﬁned layers that are generated in a spatially
and temporally-regulated manner thanks to the interplay of intrinsic
molecular programs and extracellular cues (Tiberi et al., 2012).
Impaired development of this brain structure has been associated with
mental deﬁciency and other major neurological disorders (Lewis and
Sweet, 2009; Rubenstein, 2010; Sun and Hevner, 2014).
Around 80% of neocortical neurons are excitatory projection neurons
that extend axons to distant intracortical targets and to subcortical
regions, whilst the remainder are inhibitory interneurons involved in
local circuits (DeFelipe et al., 2013; Greig et al., 2013). The distinctrogenitor;NSC, neural stemcell;
ne
cular de Barcelona (CSIC), Parc
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rbonés).
. This is an open access article undertypes of projection neurons are produced in the dorsolateral telenceph-
alon (pallium) of the embryo frommultipotent neural stem cells (NSCs)
known as radial glia (RG), and frommore restricted progenitors, the in-
termediate progenitors (IPs). These neurons are generated in an inside–
outside pattern, ﬁrst generating the neurons that form the layer closest
to the ventricle (layer VI) and lastly those that form themost superﬁcial
layers (Layers II–III). Projection neurons within a layer have common
molecular characteristics and connectivity patterns, which they acquire
at their birth (Greig et al., 2013; Molyneaux et al., 2007).
During neurogenesis, RG progenitors divide asymmetrically in the
ventricular zone (VZ) producing another RG cell and either a neuron
or an IP (Noctor et al., 2004; Haubensak et al., 2004; Miyata et al.,
2004). This progenitor moves to a more basal proliferative layer, the
subventricular zone (SVZ), where it divides symmetrically to produce
a pair of neurons directly or it does so after 1 to 3 rounds of symmetric
amplifyingdivisions (Noctor et al., 2004; Kowalczyk et al., 2009). Conse-
quently, as neocortical development progresses and the cellularity in
the SVZ increases, IPs become the major source of projection neurons
(Breunig et al., 2011; Kowalczyk et al., 2009). According to this model,
the number and proportion of projection neuron subtypes in a cortical
radial column are related to the number of RG progenitors that arethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(apical) and SVZ (basal) proliferative and neurogenic divisions
(Huttner and Kosodo, 2005; Noctor et al., 2001, 2007).
Regulation of the cell cycle, and particularly of the G1 phase of the cell
cycle, is important for the normal expansion of the neocortex in both
rodents and primates (Dehay and Kennedy, 2007). G1 is a critical phase,
integrating extracellular signals that induce either commitment to a
further round of cell division, or withdrawal from the cell cycle and
differentiation (Cunningham and Roussel, 2001; Dehay and Kennedy,
2007; Salomoni and Calegari, 2010; Zetterberg et al., 1995). Pioneering
cumulative S-phase labelling experiments performed in the mouse em-
bryo showed that as neurogenesis progresses the cell cycle of neocortical
progenitors extends due to a progressive lengthening of the G1 phase
(Takahashi et al., 1995). Moreover, there is evidence of a correlation
between cell cycle length and neurogenesis, which has led to the formu-
lation of the cell cycle length hypothesis (Gotz and Huttner, 2005).
According to this hypothesis, the time that a progenitor spends in G1
determines the ﬁnal effect of a particular cell fate determinant, which
could be equivalent (symmetric divisions) or distinct (asymmetric
divisions) in the two daughter cells (Dehay and Kennedy, 2007; Gotz
and Huttner, 2005; Salomoni and Calegari, 2010). Indeed, it was more
recently shown thatmanipulating the duration of theG1phase in neocor-
tical apical progenitors alters the production of IPs and neurons (Lange
et al., 2009; Pilaz et al., 2009).
Down syndrome (DS), themost common genetic cause of intellectual
disability, is caused by trisomy of chromosome 21. DS brains are smaller
than normal brains and they exhibit neuronal deﬁcits in several regions,
including the cerebral cortex (Ross et al., 1984). Infants with DS also
present hypocellularity in this brain structure (Schmidt-Sidor et al.,
1990; Wisniewski, 1990), indicating that defects in prenatal develop-
ment are a major determinant of the deﬁcit in adults. Indeed, fewer
cells (Larsen et al., 2008) and disorganized laminas are evident in the
cerebral cortex of DS foetuses from as early as the second trimester of
gestation (Golden and Hyman, 1994).
The availability of DS mouse models in which different regions of
chromosome 21 are in trisomy (Haydar and Reeves, 2012; Liu et al.,
2011) has allowed the effect of trisomic genes on prenatal development
to be assessed, assigning phenotypic aspects of the syndrome to a region
of chromosome 21. In the best studied model of DS, the Ts65Dn mouse
(Reeves et al., 1995), the growth of theneocorticalwall is delayed due to
the impaired production of neurons early in neurogenesis that is con-
comitant with a lengthening of the cell cycle in the ventricular germinal
layer (Chakrabarti et al., 2007). The Ts1Cje mouse is a DS model with a
smaller trisomic region than the Ts65Dn mouse (Haydar and Reeves,
2012), yet it also develops an abnormally thin neocortex and slower
cell cycle exit is observed during embryogenesis (Ishihara et al., 2010).
Importantly, the proliferation markers expressed in the neocortical
germinal matrix of DS foetuses also suggest cell cycle defects which
underpin the reduced neuron production (Contestabile et al., 2007).
There are around 80 genes in the triplicated segment common to
Ts65Dn and Ts1Cje mice, which contains the DS critical region (DSCR)
of chromosome 21 (Delabar et al., 1993; Toyoda et al., 2002). Thus, it
is likely that dosage imbalance of one or a few genes in this region
contributes to the deﬁcit of cortical neurons in DS.
In this study we have assessed the possibility that triplication of
DYRK1A, a DSCR gene, contributes to the hypocellularity of the cerebral
cortex associated with DS. DYRK1A (dual-speciﬁcity tyrosine-(Y)-
phosphorylation regulated kinase 1A) encodes a constitutively active
kinase that phosphorylates serine and threonine residues in a variety
of substrates (Becker and Sippl, 2011). In humans, truncatingmutations
in the DYRK1A gene cause primary microcephaly (Courcet et al., 2012)
and autism (O'Roak et al., 2012). Moreover, mice and ﬂies with
haploinsufﬁciency of the Dyrk1a/minibrain genes have smaller brains
(Fotaki et al., 2002; Tejedor et al., 1995), indicating that the role of
DYRK1A in brain growth is conserved across evolution. Experiments
on neural progenitors derived from induced pluripotent stem cellsfrom monozygotic twins discordant for trisomy 21 highlight DYRK1A
as one of the chromosome 21 genes important for the proliferation
and differentiation defects associated with DS (Hibaoui et al., 2014).
However, despite the evidence from different model systems showing
that DYRK1A regulates neural proliferation and differentiation
(Tejedor and Hammerle, 2011), the pathogenic effects of DYRK1A
overexpression in the formation of brain circuits in DS remain unclear
(Haydar and Reeves, 2012).
The effect of DYRK1A overexpression on cortical neurogenesis has
been assessed in the mouse embryo through electroporation, although
the results obtained were inconclusive. The ectopic overexpression of
DYRK1A in progenitors of the dorsal telencephalon induced prolifera-
tion arrest (Hammerle et al., 2011; Yabut et al., 2010), provoking
premature neuronal differentiation (Yabut et al., 2010), a phenotype
that is quite opposite to the growth delay of the cortical wall observed
in the Ts65Dn embryos (Chakrabarti et al., 2007). These studies
involved electroporation at mid-corticogenesis stages and the levels of
DYRK1A overexpression were not controlled. More recent experiments
showed that modest DYRK1A overexpression does not disturb the birth
of cortical neurons when induced at the onset of neurogenesis
(Kurabayashi and Sanada, 2013). Thus, the effect of DYRK1A on cortical
neurogenesis seems to depend on the time and/or the level of
overexpression.
Usingmouse models that overexpress Dyrk1a under its endogenous
regulatory sequences, mimicking the situation in DS, we now demon-
strate that trisomy of Dyrk1a is sufﬁcient to lengthen the G1 phase of
the cell cycle and to bias the production of RG-derived neurons and
IPs during the early phase of corticogenesis, and that the triplication of
the Dyrk1a gene is necessary for dampened early neurogenesis in the
developing neocortex of Ts65Dn embryos.
2. Materials and Methods
2.1. Animals
In this study we have used embryos and postnatal Dyrk1a+/−mice,
mBACTgDyrk1a mice, Ts65Dn mice and their respective wild-type
littermates, as well as the mice resulting from crosses between
Ts65Dn females and Dyrk1a+/− males. The day of the vaginal plug
was deﬁned as E0.5, and the day of birth was deﬁned as P0.
The generation of Ts65Dnmice,Dyrk1a+/−mice andmBACtgDyrk1a
micewas described elsewhere (Davisson et al., 1993; Fotaki et al., 2002;
Guedj et al., 2012). Mice were maintained in their original genetic
backgrounds: Dyrk1a+/−mice by repeated backcrossing of Dyrk1a+/−
males to C57BL/6Jx129S2/SvHsd F1 females (Harlan Laboratories);
mBACtgDyrk1a mice by repeated backcrossing of transgenic males to
C57BL6/J females (Charles River Laboratories); and Ts65Dn mice by
repeated backcrossing of parental Ts65Dn females (Jackson Labora-
tory, USA) to B6EiC3 males (Harlan laboratories). Dyrk1a+/− and
mBACtgDyrk1a mice were genotyped by PCR (Fotaki et al., 2002;
Guedj et al., 2012) and Ts65Dn mice by PCR (Reinholdt et al., 2011) or
by quantitative PCR (http://www.jax.org/cyto/quanpcr.html).
All the experimental procedures were carried out in accordance
with the European Union guidelines (Directive 2010/63/EU) and the
followed protocols were approved by the ethics committee of the Parc
Cientíﬁc de Barcelona (PCB).
2.2. Tissue Preparation for Histology
To obtain embryonic tissue,whole headswereﬁxedby immersion in
4% paraformaldehyde (PFA) for 24 h at 4 °C, cryoprotected with 30%
sucrose in PBS, embedded in Tissue-Tek O.C.T. (Sakura Finetek), frozen
in isopentane at −30 °C and sectioned on a cryostat. Cryosections
(14 μm) were collected on Starfrost precoated slides (Knittel Glasser)
and distributed serially. Postnatal P0 and P7 mice were deeply anaes-
thetized in a CO2 chamber and transcardially perfused with 4% PFA.
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above, and cryotome (40 μm) sections were then distributed serially.
For DYRK1A and PDGFRα immunostainings in embryos, the post-ﬁxed
brains were embedded in 2% agarose and sectioned directly on a
vibratome (40 μm).
2.3. Immunostainings and Cell Counts
For accurate immunostainingwith some antibodies (see Supplemen-
tary information) it was necessary to perform an antigen retrieval treat-
ment before blocking: sections were boiled for 10 min in sodium citrate
buffer (2 mM citric acid monohydrate, 8 mM tri-sodium citrate
dihydrate, pH 6.0). For BrdU immunostaining, sections were incubated
before blocking in 50% formamide in 2× SSC at 64 °C for 10min followed
by an incubation in 2 N HCL at 37 °C for 30 min and ﬁnally 10 min in
0.1 M boric acid (pH 8.5) at room temperature (RT). The sections were
blocked for 1 h at RT in PBS containing 0.2% Triton-X100 and 10% foetal
bovine serum (FBS) and probed for 12 to 48 h at 4 °C with the primary
antibodies diluted in antibody buffer (AB: PBS containing 0.2% Triton-
X100 and 5% FBS). Sections were washed and primary antibodies
detected by using Alexa-555 and Alexa-488 conjugated secondary
antibodies (1:1.000; Life Technologies). Cell nuclei were stained with
Hoechst (Sigma-Aldrich). For antibodies against BrdU and Pax6, and
against Cyclin D1 (in E13.5, E16.5 and E18.5 brain sections) signal
ampliﬁcation was required: after washing primary antibodies, sections
were incubated with the corresponding biotinylated secondary
antibody (1:200; Vector Labs), washed and incubated with Alexa-488
conjugated streptavidin (Life Technologies). In all cases, the speciﬁcity
of the immunoreaction was tested by omitting the primary antibody.
A complete list of the primary antibodies can be found in Supplementary
data.
Images were taken using the Leica TCS SP5 confocal microscope or
the LeicaAF7000motorizedwide-ﬁeldmicroscope. Labelled cells in em-
bryonic sections were counted in a 100 μm-wide column of the lateral
cortical wall, with the exception of cleaved-caspase3+ cells that were
counted in a 400 μm-wide column at E11.5 and in 1400 μm width
column at E14.5, and pH3+ cells, Olig2+ cells and EdU-labelled cells
that were counted in 600 μm-, 300 μm- and 250 μm-wide columns,
respectively. Labelled cells in postnatal sections were counted in a
wide column of 350 μm in Fig. 6B and in a wide column of 200 μm in
Fig. 7D and Supplementary Figs. 9 and 12. All cell counts were blind
and performed in a minimum of 3 sections of the same rostro-caudal
level per embryo or mice.
2.4. Measurements of Cytoplasmic and Nuclear Cyclin D1
Relative cytoplasmatic and nuclear Cyclin D1 protein levels were
estimated in confocal images of brain sections stained for Cyclin D1
and the nuclei labelledwithHoechst. First, imageswere converted to bi-
nary images by applying a threshold level on them using the Image-J
software. Cytoplasmatic Cyclin D1 was assigned to the Cyclin D1 signal
that did not overlap with the Hoechst signal and was obtained by
subtracting the Hoechst binary image to the Cyclin D1 binary image.
Nuclear Cyclin D1 corresponded to the Cyclin D1 signal that overlapped
with the Hoechst signal and was obtained by subtracting the
cytoplasmatic Cyclin D1 binary image to the total Cyclin D1 binary
image (see Supplementary Fig. 2C and D). Labelling intensities of total,
nuclear and cytoplasmatic Cyclin D1 were obtained in each image
using the integrated density option of the Image-J software. Cyclin D1
measurements were done in the medial region of the dorso-lateral VZ
within a rectangle of 250 μm × 50 μm in E11.5 and E13.5 sections or
in a rectangle of 250 μm × 40 μm in E16.5 sections. As a consequence
of the interkinetic nuclear movement of RG progenitors (Gotz and
Huttner, 2005), the majority of progenitors with their nuclei in the
intermediate VZ region should be in G1 or in G2.2.5. Cell Cycle Exit Rates and Cell Cycle Parameters
For cell cycle exit rate quantiﬁcations, pregnant females were intra-
peritoneally injected with one pulse of BrdU (100 mg/kg; Sigma) and
sacriﬁced 24 h later. Embryos were collected and processed as describe
above. Sections were immunostained for BrdU and Tbr1 (E12.5 embry-
os) or for BrdU and Ki67 (E14.5 embryos). Neuronal production was
estimated in E12.5 embryo sections counting the proportion of BrdU
immunolabelled cells that were Tbr1+. Cell cycle exit rates were
estimated in E14.5 embryo sections counting the proportion of BrdU
immunolabelled cells that were negative for Ki67.
Cell cycle duration of radial glial progenitors was measured in vivo
following the S-phase cumulative EdU labelling protocol described by
Arai et al. (2011). Brieﬂy, pregnant females (E11.5) were repeatedly
injected with EdU (3.3 mg/kg; Life Technologies), every hour for the
ﬁrst ﬁve injections and every 2 h for the remaining ones, and sacriﬁced
at different time points according to the schedule shown in Fig. 2A.
Embryoswere post-ﬁxed, cryoprotected and cryosectioned as described
before. EdU was detected in coronal sections using the Click-iT EdU
Alexa Fluor 647 kit (Life Technologies) according to manufacturer's
instructions. EdU cell counts were performed in a 250 μm-wide ﬁeld
of the dorsolateralwall in aminimumof 3 sections per embryo. The pro-
portion of Hoechst-stained nuclei in the VZ that were EdU+, Tuj1− and
Tbr2− at the different times of cumulative labelling (labelling index)
were plotted (see Fig. 2C) as described previously (Nowakowski et al.,
1989; Takahashi et al., 1995) to estimate the growth fraction, GF
(fraction of cells that are proliferating and that correspond to the
maximum labelling index); the cell cycle duration, Tc; and the S-
phase duration, Ts. Tc and Ts were calculated taking into account the
Tc–Ts value, which is the cumulative labelling time required to achieve
the maximum labelling index, and the Ts/Tc value was given by the in-
tersection of the extrapolation of the linear regression line to the Y axis.
To generate the best ﬁtted-regression lines we applied the Linear Re-
gression Model of the Prism software (version 5; GraphPad software)
to the averaged labelling indexes of the time points before reaching
the GF. The slopes of the best-ﬁtted lines in wild-type and TgDyrk1a
samples were analysed for statistical signiﬁcance with the same
software.
For estimating duration of G2 and M phases, sections from embryos
exposed to EdU for 1, 2 or 3 h were immunostained against pH3 to
identify mitotic progenitors and EdU visualized as before. Mitotic
progenitors at the apical surface were counted in a 250 μm-wide ﬁeld
in a minimum of 3 sections per embryo. G2 duration was considered
as the time required for half-maximal appearance of EdU in mitotic
progenitors (see Fig. 2D), and M phase duration to the proportion of
VZ progenitors that were in mitosis (pH3+ cells) multiply to the total
cell cycle duration as described in Arai et al. (2011). All these values
were then used to calculate the duration of G1 phase.
2.6. Western Blotting
Total protein extracts (≈40 μg) were resolved by SDS-PAGE and
transferred onto a nitrocellulose membrane (Hybond-ECL, Amersham
Biosciences) or Immobilon P membranes (Millipore) that was probed
with antibodies whose binding was detected by infrared ﬂuorescence
using the LI-COR Odyssey IR Imaging System V3.0 (LI-COR Biosciences)
or by chemiluminescence using the Amersham ECL™Western blotting
detection reagent (Amersham Life Sciences) and X-ray Films (AGFA).
Primary antibodies used were: mouse monoclonal anti-DYRK1A
(1:500; Abnova Corporation or 1:1000; Santa Cruz), anti-p27 (1:500;
BD Biosciences), anti-p21 (1:200; Santa Cruz), anti-vinculin (1:5000;
Sigma-Aldrich) and anti-Cyclin D1 (1:200, Calbiochem); rabbit
polyclonal anti-Cyclin D1 (1:2,000; Thermo Scientiﬁcs), anti-actin
(1:5000; Sigma-Aldrich), anti-retinoblastoma (1:500; BD Biosciences),
anti-HSP90 (1:2000; BD Biosciences), anti-pT286-cyclin D1 (1:500;
Cell Signalling), anti-GFP (1:1000, Roche) and anti-RCAN1 (1:1000).
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Cruz. Secondary antibodies for infrared ﬂuorescent detection were
goat anti-mouse IgG IRDye-800CW and goat anti-rabbit IgG IRDye-
680CW, and for chemiluminescence detection were rabbit anti-mouse
and goat anti-rabbit IgG conjugated to horseradish peroxidase
(1:2000; Dako).
2.7. RNA Extraction and Real-time qPCR
Total RNA from the telencephalon of E10.5 and E11.5 embryos were
extracted using the RNeasy Mini kit (Qiagen) according to
manufacturer's instructions and the eluted RNA treated with DNAse
(Ambion) for 30 min at 37 °C. cDNAs were synthesized from 1 μg of
total RNA using Superscript II retrotranscriptase (Life Technologies)
and random hexamers (Life Technologies). Real-time qPCR was carried
out with the Lightcycler 480 platform (Roche) using SYBR Green I Mas-
ter Kit (Roche). Peptidyl-prolyl isomerase A (Ppia) was used as reference
gene for data normalization. A complete list of the primers used can be
found in Supplementary data.
2.8. Statistical Analysis
Data are presented as the mean ± S.E.M. and were analysed by the
two-tailed Student's t-test with the exception of the EdU labelling
index data thatwas analysed as indicated beforewith the Linear Regres-
sionModel of the Prism software. Aminimumof three embryos ormice
of the same genotype was analysed in each experiment. Differences
were considered signiﬁcant at p-values b 0.05: *p b 0.05, **p b 0.001
and ***p b 0.0001.
3. Results
3.1. Neocortical RG Progenitors in TgDyrk1a Embryos Have Reduced Levels
of Nuclear Cyclin D1
During the neurogenic phase of neocortical development, DYRK1A is
expressed in progenitors of the VZ (Pax6+ cells) aswell as in progenitors
of the SVZ (Tbr2+ cells) (Supplementary Fig. 1). As ectopic overexpres-
sion of DYRK1A induces cell cycle exit in neural cells (Park et al., 2010;
Yabut et al., 2010), we asked whether triplication of Dyrk1a gene is suf-
ﬁcient to affect the expression of cell cycle regulators in cortical neural
progenitors in vivo. To this end, we used a transgenic mouse model, the
mBACtgDyrk1amouse (TgDyrk1a hereafter), which carries in a BAC the
whole Dyrk1a gene (Guedj et al., 2012). There is evidence showing that
DYRK1A can induce cell cycle exit in neural progenitors by different
means; promoting the nuclear export and degradation of the cell cycle
activator Cyclin D1 (Yabut et al., 2010), inducing the expression of the
Cdk inhibitors p27KIP1 (Hammerle et al., 2011) and p21CIP1 (Park et al.,
2010), and promoting the stabilization of p27KIP1 protein (Soppa et al.,
2014). Therefore, we compared the mRNA and protein levels of these
cell cycle regulators in the telencephalon of wild-type and TgDyrk1a
embryos at the beginning of neurogenesis (E11.5), which is mainly
formed by the germinal VZ (see Supplementary Fig. 1A). Consistent
with the genetic complement, Dyrk1amRNA and protein levels were in-
creased (1.5–1.7 fold) in the telencephalon of transgenic embryos when
compared to the wild-type (Fig. 1A and B). mRNA and protein levels of
the cell cycle regulators examined were the same in both genotypes
with the exception of Cyclin D1 protein levels that were decreased in
the TgDyrk1a embryos (Fig. 1A and B). Similarly, E10.5 TgDyrk1awhole
embryos exhibited reduced Cyclin D1 protein levels but normal levels
of Cyclin D1, p27KIP1 and p21CIP1 mRNA transcripts (Supplementary
Fig. 2A and B). Thus, a 1.5-fold increase in DYRK1A at the beginning of
neurogenesis diminished Cyclin D1 protein content in the mouse em-
bryo irrespective of the cell type. We also performed immunostaining
for Cyclin D1 and found that the levels of Cyclin D1 in the nuclei of RGprogenitors were signiﬁcantly decreased in E11.5 TgDyrk1a embryos
(Fig. 1C and Supplementary Fig. 2C and D).
One of themain nuclear functions of Cyclin D1 is to promote G1-to-S
phase transition through association with and activation of Cdk4/6.
This leads to the phosphorylation of the retinoblastoma protein
(pRb), which promotes the release of E2F transcription factor from
the pRb/E2F complex and the expression of genes necessary for cell
cycle progression (Cunningham and Roussel, 2001). Consistent
with the decreased levels of nuclear Cyclin D1 (Fig. 1C), the relative
amount of hyperphosphorylated Rb in the telencephalon of E11.5
TgDyrk1a embryos was lower than in the wild-types (Fig. 1D), indi-
cating that a 1.5-fold increase in DYRK1A is sufﬁcient to reduce
Cyclin D-Cdk activity in telencephalic RG progenitors at the onset
of neurogenesis.
Nuclear export of Cyclin D1 and its subsequent degradation via the
ubiquitin–proteasome pathway requires the phosphorylation of Cyclin
D1 at threonine 286 (T286) (Diehl et al., 1997). Whilst glycogen
synthase kinase 3 beta (GSK3β) was thought to be the only kinase re-
sponsible for phosphorylating Cyclin D1 on T286 (Diehl et al., 1998),
the demonstration that DYRK1A could promote the nuclear export
and turnover of Cyclin D1 in Neuro2a progenitor cells (Yabut et al.,
2010) raised the possibility that DYRK1A might also be a ‘T286 kinase’,
providing a mechanism for the reduction in Cyclin D1 levels. However,
since the class I DYRKs (DYRK1A and DYRK1B) can also act as priming
kinases for GSK3β, attribution of DYRK1A as a T286 kinase requires
careful mapping of phosphorylation in vitro and in vivo. Indeed, we re-
cently showed unambiguously that DYRK1B was able to phosphorylate
Cyclin D1 directly at T286 in vitro and in cells independently of GSK3β
(Ashford et al., 2014). Here we applied the same analysis to determine
if DYRK1A could phosphorylate Cyclin D1 at T286. First, using [γ-32P]
ATP in in vitro kinase reactions, we found that recombinant DYRK1A
could phosphorylate puriﬁed recombinant wild-type Cyclin D1 but
not Cyclin D1-T286A (Supplementary Fig. 3A). Second, recombinant
wild-type Cyclin D1 that was phosphorylated by DYRK1A in these
in vitro reactions was detected by a phospho-speciﬁc pT286 antibody
whereas Cyclin D1-T286A was not (Supplementary Fig. 3B). These
results demonstrated that DYRK1A could directly phosphorylate
Cyclin D1 at T286 in vitro. To assess whether DYRK1A could also
promote pT286 in cells we co-expressed DYRK1A and Cyclin D1 in
HEK293 cells and mapped phosphorylation by mass spectrometry.
As with DYRK1B previously (Ashford et al., 2014), we detected
only a single phospho-peptide and this was phosphorylated at
T286 (Supplementary Fig. 3C). Consistent with this, co-expression
of DYRK1A and Cyclin D1 promoted phosphorylation of Cyclin
D1 at T286 as detected by the pT286 antibody (Supplementary
Fig. 3D). Finally, a catalytically inactive mutant of DYRK1A (KD, ki-
nase dead, K188R) failed to promote pT286 and the pT286 antibody
failed to detect DYRK1A-driven phosphorylation of Cyclin D1-T286A
in cells (Supplementary Fig. 3E). These results conﬁrm and extend
published work (Chen et al., 2013; Soppa et al., 2014) and show
that as with DYRK1B (Ashford et al., 2014) DYRK1A is a bona ﬁde
Cyclin D1 kinase that can phosphorylate T286.
The mouse Cyclin D1 gene, like its human counterpart, expresses
two spliced mRNA variants (Wu et al., 2009); one encodes the
canonical Cyclin D1 isoform that contains T286 in its carboxy-
terminus, and the other encodes a longer protein isoform with a
distinct carboxy-terminal domain that lacks the phosphorylation
consensus sequence for DYRK kinases. We could not directly assess
Cyclin D1 phosphorylation in TgDyrk1a embryos because pT286
antibodies failed to detect endogenous phosphorylated Cyclin D1.
However, our immunoﬂuorescence and Western blot results
showed reduced levels of nuclear Cyclin D1 and the speciﬁc loss of
the shorter Cyclin D1 isoform bearing T286 (Fig. 1B–C and Supple-
mentary Fig. 2B) in TgDyrk1a embryos, strongly suggesting that
DYRK1A phosphorylates T286 in Cyclin D1 in vivo to regulate Cyclin
D1 levels.
Fig. 1. TgDyrk1a RG progenitors show decreased levels of nuclear Cyclin D1 and hyperphosphorylated retinoblastoma. (A) Relative mRNA levels of Dyrk1a, p27KIP1, p21CIP1 and Cyclin D1
determined by RT-PCR on mRNA obtained from the telencephalon of E11.5 wild-type (WT) and TgDyrk1a embryos. (B) Representative Western blots of extracts prepared from the tel-
encephalon of E11.5 embryos and probed with the indicated antibodies. Histograms show the protein levels in TgDyrk1a embryos normalized to actin or vinculin levels and expressed
relative to the WTs. Arrowhead indicates the band corresponding to the Cyclin D1 isoform that contains T286 and asterisk indicates the band corresponding to Dyrk1a. (C) Picture of
an E11.5 coronal brain section with nuclei visualized with Hoechst indicating the region in the dorsal telencephalon (Tel) where quantiﬁcations were done (image on the left), and WT
and TgDyrk1a (Tg) sections immunostained for Cyclin D1 (images on the right). The histogram shows the labelling densities (L.D.) of Cyclin D1 ﬂuorescence signals in the nucleus and
cytoplasm of radial glial progenitors of the ventricular zone (VZ) region indicated by the yellow square and calculated as shown in Supplementary Fig. 2C and D. C, caudal; Di, Diencephalon;
Tel, Telencephalon; R, rostral. (D) Representative Western blot and its quantiﬁcation showing the levels of retinoblastoma (pRb) that is hyperphsophorylated (pp-Rb) in E11.5 WT and
TgDyrk1a total telencephalic extracts. Histogram values are the mean ± S.E.M. *P b 0.05, ***P b 0.001 (n ≥ 3). Bars = 500 μm (left picture in C) and 20 μm (right pictures in C).
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Cycle Duration
The results presented so far suggested that DYRK1A-dependent
phosphorylation of T286 in Cyclin D1might provide ameans of regulat-
ing Cyclin D1-Cdk activity in RG progenitors. Indeed, in ﬁbroblast
cells the phosphorylation of Cyclin D1 by DYRK1A induces a dose-
dependent increase in the duration of the G1 phase (Chen et al.,
2013). Given the importance of Cyclin D-Cdk activity in cell cycle pro-
gression, we wanted to know whether the deﬁcit of Cyclin D1 in
TgDyrk1a RG progenitors was affecting G1 phase duration. To test this
possibility, we estimated the duration of the total cell cycle and the
length of the different cell cycle phases in telencephalic RG progenitors
of E11.5 wild-type and TgDyrk1a embryos by assessing the accumula-
tion of 5-ethynyl-2′deoxyuridine (EdU) in vivo, as described previously
(Takahashi et al., 1993; Arai et al., 2011) (see schedule in Fig. 2A). The
growth fraction (GF) of RG progenitors (nuclei in the VZ that do notexpress Tbr2 or Tuj1; Fig. 2B) reached the maximum labelling index
value in both genotypes (Fig. 2C), indicating that all progenitors were
cycling. However, total cell cycle duration (Tc) and S phase duration
(Ts) calculated from the best ﬁtted slope deﬁned by the increasing
labelling index values (Fig. 2C) were increased by 4.8 h and by 2.8 h, re-
spectively, in the transgenic progenitors overexpressing DYRK1A
(Fig. 2E). Duration of the G2 and M phases, measured by combining
EdU labelling with staining for phospho-Histone 3 (pH3) to label cells
in mitosis (Fig. 2D), was similar in both genotypes (Fig. 2E). In contrast,
the duration of the G1 phase, derived by subtracting the duration of
the S/G2/M phases from the Tc value, was 1.9 h longer in TgDyrk1a
progenitors than in the wild-type. Thus, cell cycle lengthening in RG
progenitors overexpressing DYRK1A results from an increased duration
of the G1 and S phases. S phase durations in E11.5 wild-type and
TgDyrk1a RG progenitors assessed by the IdU, BrdU double-labelling
method described in Martynoga et al. (2005) (see Supplementary
Fig. 4A–C) also showed that transgenic progenitors overexpressing
Fig. 2. TgDyrk1a RG progenitors have longer cell cycles due to an enlargement of the G1 and S phases. (A) Schedule of the cumulative EdU-labelling protocol employed to calculate the cell
cycle parameters in E11.5 radial glial progenitors of the dorsal telencephalon. Red and orange arrows indicate the time points at which EdU was injected and the time points at which
embryos were harvested, respectively. (B) Representative confocal images of brain sections from wild-type embryos exposed to EdU for the indicated time and stained for EdU, Tuj1
and Tbr2. Nuclei were visualizedwith Hoechst. CP, cortical plate; SP, subplate; VZ, ventricular zone. (C) Plot showing the labelling indexes (L.I.; proportion of EdU-labelled nuclei) of radial
glial progenitors (Tbr2−, Tuj1− cells in the VZ) inwild-type and TgDyrk1a embryos at the indicated time of EdU exposure. GF, growth fraction (dashed red line); Tc, cell cycle duration; Ts,
S-phase duration; Tc-Ts, time at which the labelling index reaches the GF (dashed black lines). (D) Representative image of a section from awild-type embryo (2 h EdU exposure) stained
for EdU and pH3 and nuclei visualized with Hoechst. The plot shows the mitotic L.I. (proportion of EdU-labelled radial glial progenitors in mitosis (pH3+)) at the indicated times of EdU
exposure in wild-type and TgDyrk1a embryos. TG2, G2-phase duration. Arrows in the image point to the mitotic nuclei (green) that were labelled for EdU (grey). (E) Table summarizing
the cycle parameters of wild-type and TgDyrk1a radial glial progenitors. Estimation of G1 and M phase durations is described in Materials and Methods. L.I. values (in C) and mitotic L.I.
values (in D) are themean±S.E.M. (n≥ 4). The P value indicated in Cwas obtained using the Linear RegressionModel of the Prism software as indicated inMaterials andMethods. Bars=
20 μm.
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tary Fig. 4D). The increase in S phase duration calculated in this experi-
ment (28% increase with respect to the wild-types) was similar to the
increase calculated by assessing the accumulation of EdU (35%; Fig. 2E).
However, we did ﬁnd signiﬁcant differences between the Ts values calcu-
lated in the two experiments (Fig. 2E and Supplementary Fig. 4D). This
discrepancy should be taken into consideration when comparing cell
cycle parameters assessed using different methodologies.
Together, these results indicate that a 1.5-fold increase in DYRK1A
protein is sufﬁcient to lower Cyclin D1 levels and alter cell cycle param-
eters of RG progenitors, lengthening G1 phase, consistent with the
ability of DYRK1A to promote phosphorylation of T286 in Cyclin D1.
3.3. DYRK1A Modiﬁes the Proportion of RG-derived Neurons and IPs in a
Dosage-dependent Manner
Given the established linkbetweenG1 phase duration and the fate of
the progenitor daughters (Calegari et al., 2005; Salomoni and Calegari,
2010), we then asked whether a moderate increase in G1 phase dura-
tion in RG progenitors is sufﬁcient to affect their neurogenic potential.
To this end, we counted the number of cells expressing neural markers
in brain sections of E11.5 wild-type and TgDyrk1a embryos. The
thickness of the dorsal telencephalic VZ at this stage and the number
of RG progenitors (Pax6+ cells) were very similar in both genotypes
(wild-type, 110.7 ± 3.19 μm; TgDyrk1a, 111.8 ± 3.72 μm and Fig. 3A).
In contrast, TgDyrk1a embryos have fewer cells expressing the neuronalmarker Tbr1 than wild-type embryos (Fig. 3B). This reduction was not
due to increased cell death, since the number of apoptotic cells
immunolabelled for active caspase3 was similar in both genotypes
(cells in a 400 μm-wide column were 1.95 ± 0.16 and 1.96 ± 0.31
in wild-type and in TgDyrk1a embryos, respectively; see also Supple-
mentary Fig. 5A). Thus, the deﬁcit of differentiating neurons in the
transgenic embryos likely results from impaired neuron production.
Indeed, experiments in which the S phase marker BrdU was injected
into pregnant females at E11.5 and embryos analysed 24 h later showed
a 40% reduction in RG-derived neurons (proportion of BrdU+ cells
expressing Tbr1) in TgDyrk1a embryos with respect to the wild-types
(Fig. 3C). This reduction cannot be explained only by the moderate
lengthening of the cell cycle observed (28% respect to the wild-types;
Fig. 2E), suggesting a possible bias in the division mode of RG progeni-
tors in the transgenic embryos.
During the neurogenic phase of neocortical development, RG self-
renewing divisions produce either one neuron or one IP (Noctor et al.,
2004; Haubensak et al., 2004; Miyata et al., 2004). The transition of a
RG progenitor to an IP is associated with the downregulation of Pax6
and the upregulation of Tbr2 (Englund et al., 2005),which is a transcrip-
tion factor required for IP speciﬁcation and marks this progenitor type
(Sessa et al., 2008). The Pax6–Tbr2 switch also takes place in RG-
derived neurons, but the expression of Tbr2 in these cells is shut down
as they move from the VZ to the cortical plate and start to express neu-
ronal markers. However, at the onset of IP production, by E11.5, some
neurons still have detectable levels of Tbr2 (Englund et al., 2005).
Fig. 3. Impaired early neurogenesis and increased production of IPs in TgDyrk1a embryos. (A, B, D) Representative confocal images from coronal brain sections of E11.5wild-type (WT) and
TgDyrk1a embryos showing Pax6 expression (green in A), Tbr1 and Tuj1 expression (green and red in B, respectively) and Tuj1 and Tbr2 (green and red in C, respectively). Histograms
show the numbers of Pax6+ radial glial progenitors (A), Tbr1+ neurons (B) and Tbr2+ intermediate progenitors; Tbr2+,Tuj1− cells (arrows; D) in a 100 μm-wide column of the cortical
wall. (C)Histogram showing neuronal production in the dorsal telencephalon ofWT and TgDyrk1a embryos obtained fromBrdU-injected females at E11.5 and harvested 24 h later. Values
are thepercentage of cells containing BrdU that express theneuronalmarker Tbr1 andwere obtained by counting BrdU+, Tbr1+ double immunoﬂuorescent cells in a 100 μm-wide column
of the cortical wall. Histogram values are the mean ± S.E.M. **P b 0.01, ***P b 0.001 (n = 3 in A, B, D; n = 4 in C). Bars = 20 μm. CP, cortical plate; SP, subplate; VZ, ventricular zone.
(E) Scheme summarizing the cell count results inA toD. Radial glial progenitors (Pax6+ cells in green) in thedorsal VZof bothWT and TgDyrk1a embryos divide asymmetrically producing
another Pax6 progenitor (black arrows) and a neuron (yellow cell) or an intermediate progenitor (red cell). In TgDyrk1a embryos the number of divisions producing intermediate pro-
genitors increases at the expenses of the ones producing neurons.
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stage, we counted the Tbr2+ cells that did not express the neuronal
marker Tuj1 (arrows in Fig. 3D). The cell counts showed that TgDyrk1a
embryos had more IPs than the wild-types (Fig. 3D). Together, these
observations suggest that the deﬁcit of early-born cortical neurons in
the transgenic condition may result from an increased proportion of
RG proliferative divisions at the expense of the neurogenic divisions
(Fig. 3E). As progenitors undergoing proliferative divisions have longer
S phases than the ones undergoing neurogenic divisions (Arai et al.,
2011), the bias observed in the division mode of TgDyrk1a RG progeni-
tors was consistent with the increased duration of the S phase in these
progenitors (Fig. 2E and Supplementary Fig. 4).
If DYRK1A-induced degradation of Cyclin D1 is the mechanisms by
which this kinase regulates G1 phase duration in RG progenitors and
hence the fate of their daughter cells, lowering DYRK1A protein levels
in these progenitors should also modify the proportion of neurons and
IPs they produce. To test this predictionwe did the same quantiﬁcations
in embryos heterozygous for a Dyrk1a null mutation (Dyrk1a+/−
embryos) (Fotaki et al., 2002). The levels of DYRK1A protein in the tel-
encephalon of E11.5 Dyrk1a+/− embryos were reduced (around 50%)
with respect to the levels in the Dyrk1a+/+ control littermates. Impor-
tantly, the levels of nuclear Cyclin D1 in Dyrk1a+/− dorsal RG progeni-
tors were signiﬁcantly increased (Supplementary Fig. 5B and C). As in
the TgDyrk1a gain-of-function model, there were no differences
between genotypes in the number of RG progenitors (Pax6+ cells in the
VZ; Fig. 4A). However, Dyrk1a+/− embryos had more Tbr1-expressing
neurons than Dyrk1a+/+ embryos (Fig. 4B). We could not detect any
IP cells (Tbr2+, Tuj1− cells) in E11.5 Dyrk1a+/− embryos (Fig. 4C),
indicating that IP production is impaired in this Dyrk1a mutant. To
conﬁrm this, we counted the number of Tbr2+ cells in Dyrk1a+/+ and
Dyrk1a+/− embryos two days later (at E13.5), an agewhere the germinal
SVZ is well formed. The number of these cells was reduced in the VZ ofDyrk1a+/− embryos (Fig. 4D), showing that indeed mutant RG progeni-
tors produce fewer IPs than the controls. Accordingly, Dyrk1a+/-mutants
had less IPs in the SVZ (Fig. 4D).
The opposing phenotypes of Dyrk1a gain- and loss-of-function mu-
tant embryos strongly suggest that moderate variations in the levels of
nuclear Cyclin D1 in RG progenitors bias their division mode, favouring
asymmetric proliferative divisions when Cyclin D1 levels decrease and
asymmetric neurogenic divisions when they increase (see schemes in
Figs. 3E and 4E).
3.4. Triplication of Dyrk1a Alters Neuron Production and the Onset of
Gliogenesis in the Dorsal Telencephalon
The majority of neurons in the neocortex are generated in the SVZ
from IPs (indirect neurogenesis) (Kowalczyk et al., 2009; Noctor et al.,
2007; and scheme in Fig. 5A) and, therefore, a small variation in the
number of these progenitors is expected to have a signiﬁcant impact
on neuron cellularity. Since the production of IPs is augmented
in E11.5 TgDyrk1a embryos (Fig. 3D), and DYRK1A is expressed in the
VZ and SVZ during all the neurogenic phase of cortical development
(Supplementary Fig. 6), we counted the IPs generated from RG progen-
itors (Tbr2+ cells in the VZ; Fig. 5B) and the ones in the SVZ (Tbr2+ cells
in the SVZ; Fig. 5B) in wild-type and TgDyrk1a embryos at different
developmental stages. During early neurogenesis, until E14.5, the num-
ber of Tbr2 progenitors in the VZ and SVZ increased in both wild-type
and transgenic embryos (Fig. 5A and B). However, TgDyrk1a embryos
had more Tbr2 progenitors in both germinal regions at E12.5 and
E13.5 (Fig. 5B).
Contrary to RGprogenitors that divide in theVZ, IPs divide in the SVZ
(Noctor et al., 2004; Haubensak et al., 2004; Miyata et al., 2004; and
scheme in Fig. 5A). The number of pH3+ cells in the telencephalic ven-
tricular surface (apical mitosis) was similar in wild-type and TgDyrk1a
Fig. 4. Increased early neurogenesis and decreased production of IPs inDyrk1a+/− embryos. (A to D)Representative confocal images from coronal brain sections of E11.5 (A to C) and E13.5
(D)Dyrk1a+/+ andDyrk1a+/− embryos showing Pax6 expression (A), Tbr1 and Tuj1 expression (B), Tbr2 and Tuj1 expression (C) and Tbr2 expression (D). Histograms show the numbers
of Pax6+ radial glial progenitors (A), Tbr1+ neurons (B) and Tbr2+ intermediate progenitors (D) in a 100 μm-wide column of the cortical wall. Histogram values are the mean ± S.E.M.
*P b 0.05, **P b 0.01 (n≥ 3 in A to C; n=4 inD). Bars=20 μm. CP, cortical plate; SP, subplate; VZ, ventricular zone; SVZ, subventricular zone. (E) Scheme summarizing cell count results in
A to D. Radial glial progenitors (Pax6+ cells in green) in the VZ of both Dyrk1a+/+ and Dyrk1a+/− embryos divide asymmetrically producing another Pax6 progenitor (black arrows) and
a neuron (yellow cell) or an intermediate progenitor (red cell). In Dyrk1a+/− mutants the number of divisions producing neurons increases at the expenses of the ones producing
progenitors.
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neurogenesis the number of RG divisions was not altered in Dyrk1a
transgenic embryos. Accordingly, there were no differences between
genotypes in the numbers of RG progenitors during neurogenesis
(Pax6+ cells in a 100 μm-wide column were: wild-type, 127.11 ±
7.56; TgDyrk1a, 133.83 ± 6.23 at E13.5 and wild-type, 72.61 ± 3.98;
TgDyrk1a, 80.53 ± 5.91 at E16.5). However, the number of pH3+ cells
in the SVZ (basal mitosis) was signiﬁcantly increased in E13.5 TgDyrk1a
embryos, which correlated with the increased number of IPs in the SVZ
observed at this stage (Fig. 5C).
As neurogenesis proceeds, IPs become themain source of neocortical
neurons (Kowalczyk et al., 2009; and Fig. 5A). To evaluate how the
increased number of IPs affects neuron production in the transgenic
condition, we counted all differentiating neurons in the dorsal
telencephalon of wild-type and TgDyrk1a embryos at E13.5 using the
neuronal marker Tbr1. The number of Tbr1+ cells in the transgenic
embryos was still lower at this developmental stage (Fig. 5D), but the
reduction (15%), was less severe than in E11.5 (40%). This suggests
that indirect neurogenesis is higher in TgDyrk1a embryos than in the
wild-types, partially compensating for the deﬁcit of RG-derived neurons
(Fig. 3B and C). To provide evidence for this, we labelled cells in S-phase
with BrdU at E13.5 and estimated the proportion of these cells that
exited the cell cycle 24 h later by doing double immunostaining with
BrdU and Ki67 antibodies. As shown in Supplementary Fig. 7A, cell
cycle exit rates were similar in the telencephalon of wild-type and
TgDyrk1a embryos, indicating that indeed indirect neurogenesis at this
stage is reducing the deﬁcit of early-born RG-derived neurons in embry-
os with 3 copies of Dyrk1a. Then we asked whether the advanced pro-
duction of IPs in these embryos (Figs. 3D and 5B) alters the fate of the
neurons they produce. The results of a birthdate experiment performed
by injecting BrdU into pregnant females at E13.5, when the production
of layer V callosal projection neuron peaks (Molyneaux et al., 2007),indicated that the differentiating program in the dorsal telencephalon
of TgDyrk1a embryos is slightly advanced (Supplementary Fig. 7B and
C), paralleling the advanced production of IPs.
Inwild-type embryos, during the late phase of cortical neurogenesis,
by E16.5, the production of IPs (Tbr2+ cells in the VZ; Fig. 5B) decreases
and the number of IP terminal divisions in the SVZ increases (Kriegstein
and Alvarez-Buylla, 2009; and scheme in Fig. 5A). IP production in the
VZ of TgDyrk1a embryos was normal at E14.5 and E16.5 (green rectan-
gles in Fig. 5B). The number of IPs in the SVZ of these embryos was also
normal at E14.5 but decreased at E16.5 (purple rectangles in Fig. 5B).
This decrease did not result from increased apoptosis, since the number
of cells in E14.5 embryos that expressed the active form of caspase3was
similar in both genotypes (cells in a 1400 μm-wide column were 7.9 ±
1.26 and 9.5 ± 1.50 in wild-type and TgDyrk1a embryos, respectively).
Since the number ofmitoses in the SVZ of E16.5 TgDyrk1a andwild-type
embryos was similar (Fig. 5C), the decreased number of SVZ IPs
observed in TgDyrk1a embryos at this stage (Fig. 5B) could result from
increased terminal divisions leading to an advanced exhaustion of the
IP pool. If this were the case, the production of neurons in TgDyrk1a
embryos should increase between E14.5 and E16.5. To asses this, we
counted cells in the cortical layers deﬁned by the layer-speciﬁc markers
Tbr1 and Ctip2 at E16.5 (Molyneaux et al., 2007). As predicted, the num-
ber of neurons in the external layers (deﬁned by the lack of Tbr1 and
Ctip2 expression) was augmented in TgDyrk1a embryos (Fig. 5D). At
this stage, Tbr1 is expressed in layer VI early-born neurons (Bulfone
et al., 1995) and in newborn upper layer neurons that are migrating to
their ﬁnal position and still expressed this transcription factor. The
deﬁcit of Tbr1+ neurons observed in E13.5 TgDyrk1a embryos was no
longer evident at E16.5 (Fig. 5D), which is in accordance with more
neurons being produced in the transgenic embryos at this stage. The
number of layer V neurons (cells expressing Ctip2) was not affected
by the overexpression of DYRK1A (Fig. 5D). This, together with the
Fig. 5. TgDyrk1a embryos show altered numbers of neurons and IPs along corticogenesis. (A) Scheme showing the cellularity of the ventricular (VZ) and subventricular (SVZ) germinal
layers along the neurogenic phase of neocortical development and the divisionmode of the twomain progenitor types in these layers; radial glial progenitors (in green) and intermediate
progenitors (in red). Note that cortical neurons are generated following an inside–outside pattern and thatmost of the upper layer neurons (yellowneuronswith bluenuclei) are produced
around E16.5 by terminal divisions of intermediate progenitors. (B) Representative images of wild-type (WT) and TgDyrk1a (Tg) embryonic brain sections from different developmental
stages immunostained for Tbr2 and nuclei labelled with Hoechst, and histograms showing the numbers of Tbr2+ progenitors (intermediate progenitors) in the VZ (green bars) and in the
SVZ (purple bars) in a 100 μm-wide column of the cortical wall. (C) Histogram showing the number of pH3+ cells in the VZ (green bar; apical mitosis) and in the SVZ (purple bar; basal
mitosis) in a 600 μm-wide column of the cortical wall. (D) Representative images of WT brain embryo sections of the indicated developmental stages immunostained for layer-speciﬁc
markers, and histogram showing the numbers of total neurons (Tbr1+ cells) at E13.5, and the numbers of layer VI neurons (Tbr1+ cells), layer V neurons (Ctip2+, Tbr1− cells) and layers
II–IVneurons (Ctip2−, Tbr1−Hoechst labelled cells) at E16.5 in a 100 μm-wide columnof the corticalwall. Histogramvalues are themean±S.E.M. *Pb 0.05, **P b 0.01, ***Pb 0.001 (n≥ 3).
Bars = 20 μm. CP, cortical plate; IZ, intermediate zone; SP, Subplate.
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rons in the Dyrk1a embryos are produced earlier in development but at
normal rates. In summary, our results show that a 1.5-fold increase in
DYRK1A protein levels disturbs the number of neocortical neurons
that are generated through development by direct and indirect
neurogenesis.
As neurogenesis progresses and the length of the G1 phase increases,
the levels of CyclinD1 in dorsal VZ cells progressively decrease, andby the
end of the neurogenic phase, by E18.5, Cyclin D1 immunolabelling in the
ventricular proliferative region was very faint (Supplementary Fig. 8A).
Similar to the situation at the onset of neurogenesis (Fig. 1B and C), the
levels of nuclear Cyclin D1 inversely correlated to the levels of DYRK1A
in E13.5 embryos (Supplementary Figs. 6 and 8B). In contrast and despite
DYRK1A being still present in the VZ of E16.5 embryos (Supplementary
Fig. 6), the levels of nuclear Cyclin D1 in TgDyrk1a VZ progenitors were
normal (Supplementary Figs. 6A and 8C). Consistent with published
data (Glickstein et al., 2009), we only detected a few cells expressing
high Cyclin D1 levels in the SVZ. Therefore, our expression data and
the phenotype of TgDyrk1a transgenic embryos indicate that the altered
production of upper layer neurons observed in these embryos does not
result from the regulatory action of DYRK1A on Cyclin D1 degradation.The generation ofmacroglial cells in themouse dorsal telencephalon
begins around birthwhen VZ progenitors lose their capacity to generate
neurons and become gliogenic (Kriegstein and Alvarez-Buylla, 2009).
Immunolabelling for Cyclin D1 revealed the presence of a population
of cells expressing high levels of the protein in the region above the
SVZ, the intermediate zone, of E16.5 TgDyrk1a embryos that was almost
absent in the wild-types (Supplementary Fig. 8C). Most of these cells
also expressed Platelet-derived growth factor receptor-alpha (PDGFRα)
(Supplementary Fig. 8D), which is a marker of oligodendrocyte precur-
sors (Rowitch, 2004). In accordance, TgDyrk1a embryos at this stage had
an increased number of precursors expressing the oligodendrocytic
marker Olig2 (Rowitch, 2004) (Fig. 6A). These results indicate that
TgDyrk1a RG progenitors acquire their capacity of producing glial cells
before the wild-types (Fig. 6C).
3.5. Postnatal TgDyrk1a Mice Exhibit an Altered Proportion of Neocortical
Projection Neurons
To estimate the impact of the neurogenic defects observed in
TgDyrk1a embryos, we counted the number of neurons expressing
layer-speciﬁc markers in wild-type and TgDyrk1amice at P0, just after
Fig. 6.The TgDyrk1amodel shows an advancedproduction of oligodendrocyte progenitors and decreasedneuronal cellularity in speciﬁc cortical layers. (A) Representative coronal sections
from E16.5wild-type (WT) and TgDyrk1a (Tg) brains immunostained for Olig2 and nuclei labelledwith Hoescht. Yellow dashed rectangles indicate the regionmagniﬁed in the images on
the right. Histogram shows thenumber of Olig2+ cells in a 300 μm-wide column of the corticalwall. (B) Representative coronal sections fromP7WT and Tg brains immunostained for Tbr1
(left), Ctip2 (middle) or Cux1 (right), and histograms showing the number of layer VI Tbr1+ neurons, layer V Ctip2+ neurons and layers II–IV Cux1+ neurons in a 100 μm-wide column of
the cortical wall. Values are the mean ± S.E.M. *P b 0.05, ***P b 0.001 (n≥ 3). Bars = 50 μm. CP, cortical plate; SP, subplate; VZ, ventricular zone; SVZ, Subventricular zone. (C) Schemes
showing the birth time of Tbr1 neurons, Ctip2 neurons, Cux1 neurons and oligodendrocyte precursor cells (OPCc) in the telencephalon of a WT and a Tg embryo and the progenitor type
(radial glial (green) or intermediate (red) progenitor) that produces these cells. The deﬁcits of early-born (Tbr1+) neurons and late born (Cux1+) neurons in transgenic animals result,
respectively, from the decreased neuronal production during early neurogenesis and from the premature exhaustion of the intermediate progenitor pool during late neurogenesis. Note
that the generation of OPCs is advanced in Tg embryos.
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and projection neurons are in their ﬁnal layer position (Miller, 1988).
At these developmental stages, Tbr1 expression in the neocortex is al-
most restricted to layer VI neurons (Bulfone et al., 1995), which are
mainly generated between E11.5 and E13.5 (Molyneaux et al., 2007).
According to the neuron deﬁcit observed in TgDyrk1a embryos during
this period (Figs. 3B and 5D), the number of layer VI Tbr1+ neurons in
transgenic animals was lower than in the wild-types at both P0 and
P7 (Fig. 6B and Supplementary Fig. 9A). In contrast, the number of
layer V subcerebral neurons that express high levels of Ctip2 (Arlotta
et al., 2005)was normal in TgDyrk1a postnatal animals (Fig. 6B and Sup-
plementary Fig. 9B), which is in accordancewith the normal numbers of
layer V Ctip2 neurons observed in E16.5 Dyrk1a transgenic embryos
(Fig. 5D). Superﬁcial cortical projection neurons are mostly produced
by SVZ IPs and express the transcription factors Mef2c (Leifer et al.,
1993) and Cux1 (Nieto et al., 2004). The number of layers II–IV
Mef2c+ neurons at P0 (Supplementary Fig. 9B) and of Cux1+ neurons
at P7 (Fig. 6B) was signiﬁcantly lower in TgDyrk1a animals than in the
wild-types. This correlated with the decrease in IP cell numbers
displayed by transgenic embryos from E14.5 to E16.5 (Fig. 5B). More-
over, Tbr1+, Ctip2+ and Cux1+ neurons in P7 TgDyrk1a animals had a
normal layer distribution (Fig. 6B), indicating that the overexpression
of DYRK1A did not affect radial migration of cortical differentiating
neurons.
In summary, the results presented so far show that a 1.5-fold in-
crease in DYRK1A protein levels diminishes neuron production rates
at the beginning (by E11.5) and the end (by E16.5) of dorsal cortical
neurogenesis. The deﬁcits in early-born neurons and late-born neurons
in the DYRK1A overexpressingmodel can be explained, respectively, by
the impaired production of RG-derived neurons and the early exhaus-
tion of the IP pool (see scheme in Fig. 6C).3.6. Normalization of Dyrk1a Gene-dosage Restores Cyclin D1 Protein
Levels and the Neurogenic Potential of RG Progenitors in Ts65Dn Embryos
Similar to the TgDyrk1a model, VZ progenitors of the dorsal telen-
cephalon in trisomic Ts65Dn embryos have longer cell cycle duration
than euploid progenitors. Importantly, these embryos show reduced
neuron production during the early phase of corticogenesis and a tran-
sient increase in the numbers of Tbr2+ IPs and SVZ dividing progenitors
(cells inmitosis) at later stages. As a consequence, the growth of the cor-
tical wall is delayed in trisomic Ts65Dn embryos (Chakrabarti et al.,
2007). The similarities between the Ts65Dn model and the TgDyrk1a
model reported here, suggest that the triplication of Dyrk1a contributes
to the early neurogenic cortical defects occurring prenatally in the
Ts65Dn model. To investigate this, we ﬁrst checked Cyclin D1 protein
levels in total telencephalic extracts of E11.5 Ts65Dn embryos, which
contain 1.5-fold more DYRK1A protein than the extracts from euploid
embryos. Importantly, Cyclin D1 levels were decreased in Ts65Dn
embryos (Supplementary Fig. 10). Next, we checked whether normali-
zation of Dyrk1a gene-dosage in the trisomic embryos could normalize
Cyclin D1 levels in dorsal RG progenitors. For this, we estimated the
levels of Cyclin D1 in the nucleus and cytosol of RG progenitors in em-
bryo brain sections obtained from crosses between Ts65Dn females
andDyrk1a+/−males (Fig. 7A) by using the same analysiswe did before
in TgDyrk1a embryos (Supplementary Fig. 2C and D). By E12.5, one day
after the onset of neurogenesis in the dorsal telencephalon, Cyclin D1
protein levels in Ts65DnRGprogenitorswere lower than in euploid pro-
genitors (Fig. 7B). Moreover, Cyclin D1 content in the nuclei of Ts65Dn
progenitors diminished to similar extents as in TgDyrk1a progenitors
(Figs. 1C and 7B). These data indicate that nuclear levels of Cyclin D1
in Ts65Dn apical progenitors are controlled by DYRK1A. Accordingly,
the genetic normalization of Dyrk1a dosage in Ts65Dn progenitors in-
creased the amount of total and nuclear Cyclin D1 to euploid levels
(Fig. 7B). As expected by the result presented in SupplementaryFig. 5B, RG progenitors in Dyrk1a+/− littermate embryos had more
Cyclin D1 in their nuclei than in euploid embryos (Fig. 7B).
In Ts65Dn embryos, progenitors of the telencephalic VZ have longer
cell cycle duration due to a lengthening of the G1 and S phases
(Chakrabarti et al., 2007). If G1 phase lengthening biases the type of
RG self-renewing divisions, as we propose for TgDyrk1a progenitors
(Fig. 3E), Ts65Dn RG progenitors should produce fewer neurons and
more IPs. To investigate this possibility we counted apical progenitors
(Pax6+ cells), neurons (Tbr1+ cells) and IPs (Tbr2+ cells that do not
express the neuronal marker Tuj1) in E12.5 brain sections of the four
genotypes resulting from the crosses depicted in Fig. 7A. As in the
TgDyrk1a model, the thickness of the dorsal VZ and the numbers of
Pax6+ progenitors in radial columns were similar in euploid and
Ts65Dn embryos (wild-type, 135.8 ± 3.06 μm; Ts65Dn, 131.3 ±
3.70 μm; Supplementary Fig. 11). Moreover, Ts65Dn progenitors
produced fewer neurons (Supplementary Fig. 11A and Fig. 7C) and
more IPs than euploid progenitors (Fig. 7C). The phenotype in Ts65Dn
embryos reported here is consistent with the reduced production of
early-born neurons and the increased number of Tbr2+ progenitors in
the SVZ observed at later developmental stages in these embryos
(Chakrabarti et al., 2007). Importantly, both neuron and IP numbers
were normal in Ts65Dn embryos with normal Dyrk1a gene-dosage. In
accordance with the data shown in Fig. 4B and D, Dyrk1a+/− littermate
embryos showed increased numbers of neurons and decreased number
of Tbr2+ progenitors (Fig. 7C). This data indicates that at the onset of
cortical neurogenesis triplication of Dyrk1a in Ts65Dn RG progenitors
increases the production of IPs at the expense of neurons.
The decreased early neurogenesis in Ts65Dn embryos leads to a
reduction in the number of layer VI Tbr1+ neurons in Ts65Dn postnatal
animals (Chakrabarti et al., 2007, 2010). Ts65Dn animals resulting from
crosses between trisomicmice and Dyrk1a+/−mice (Fig. 7A) had fewer
Tbr1 neurons than euploid animals (Fig. 7D). Importantly, the normali-
zation of Dyrk1a gene-dosage in the trisomic embryos also restored the
number of postnatal layer VI Tbr1 neurons (Fig. 7D). Similar to postnatal
TgDyrk1a animals, Ts65Dn mice had normal numbers of layer V Ctip2+
neurons but decreased numbers of neurons in the external layers. This
defect was reverted by decreasing Dyrk1a gene-dosage to normal levels
(Supplementary Fig. 12), suggesting that the overexpression of DYRK1A
also impacts late cortical neurogenesis in the trisomic Ts65Dn model.
In summary, these data show that increased Dyrk1a gene-dosage in
RG Ts65Dn progenitors diminishes the production of early-born neu-
rons in the developing neocortex and suggest that Dyrk1a-mediated
degradation of Cyclin D1 is likely the basis of the altered cell cycle
parameters observed previously in apical Ts65Dn progenitors.
4. Discussion
In the present study we show that a 1.5-fold increase in DYRK1A
protein levels in NSCs of the mouse developing cerebral cortex caused
by trisomy of the Dyrk1a gene lengthens the cell cycle and decreases
the production of RG-derived neurons. Three key observations indicate
that the overexpression of DYRK1A in RG progenitors favours RG asym-
metric proliferative divisions at the expense of neurogenic divisions:
(1) During the early phase of cortical neurogenesis, when the majority
of neocortical neurons are generated in the VZ by RG-asymmetric
neurogenic divisions (Kowalczyk et al., 2009), the number of IPs
(Tbr2+ cells) that delaminate from the VZ surface and migrate to the
basal surface increases in TgDyrk1a embryos whilst the number of
neurons (Tbr1+ cells) decreases; (2) the number of RG progenitors
(Pax6+ cells) and the number of mitoses in the apical surface of the
ventricle in TgDyrk1a embryos are normal during corticogenesis and
(3) the number of IPs in the SVZ of TgDyrk1a embryos increased during
the growing phase of this germinal layer. Moreover, the fact that
haploinsufﬁcient Dyrk1a+/− embryos produce fewer IPs andmore neu-
rons during early corticogenesis indicates that the effect of DYRK1A on
the division mode of RG progenitors is dosage-dependent. In both
Fig. 7. Trisomy of Dyrk1a alters early cortical neurogenesis in the Ts65Dn Down syndromemodel. (A) Scheme of the crosses to generate Ts65Dnmice (Ts-D1a+++), Ts65Dnmice with 2
functional copies of Dyrk1a (Ts-D1a++−), euploid mice monosomic for Dyrk1a (D1a+/−) and control (euploid) mice. (B–D) Representative brain coronal sections obtained from E12.5
embryos of the indicated genotypes and immunolabelled for Cyclin D1 (B), Tbr1 (C), or Tbr2 and Tuj1 (C), or from P7 postnatal mice of the indicated genotypes immunolabelled for
Tbr1 (D). Histogram in B shows the labelling density (L.D.) of Cyclin D1 ﬂuorescence signal in the nucleus and the cytoplasm of radial glial progenitors of the ventricular zone (VZ) region
indicated by the yellow rectangle and calculated as shown in Supplementary Fig. 2C and D. Histograms in C and D show the numbers of Tbr1+ neurons (C and D) and Tbr2+ intermediate
progenitors; Tbr2+,Tuj1− cells (C) in a 100 μm-wide columnof the cortical wall. Histogram values are themean± S.E.M. *P b 0.05, **P b 0.01, ***P b 0.001 (n≥ 3). Bars=20 μm inB and C,
and 50 μm in D. CP, cortical plate; SP, subplate.
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number of projection neurons in the most internal layer of the
neocortex.
The in vivo cell cycle parameters measured in RG progenitors
showed that DYRK1A overexpression speciﬁcally affects the duration
of the G1 and S cell cycle phases. Cyclin D1 has been shown to be rate
limiting for the G1-to-S phase transition (Resnitzky et al., 1994). In the
three mouse models used in this work with an imbalanced dosage of
Dyrk1a, the levels of Cyclin D1 and DYRK1A proteins during the early
phase of cortical neurogenesis were inversely correlated, indicating
that DYRK1A might induce proteolytic degradation of Cyclin D1 in RG
progenitors in vivo, as it does in some cultured mammalian cells
(Chen et al., 2013; Yabut et al., 2010), which is consistent with the abil-
ity of DYRK1A to phosphorylate T286 in Cyclin D1. Whilst DYRK1A has
been shown to increase both p21CIP1 (Park et al., 2010) and p27KIP1
levels (Soppa et al., 2014) in cell culturemodels we observed no change
in the levels of these proteins in TgDyrk1a embryos. Thus changes in
Cyclin D1, and not p21CIP1 or p27KIP1, are most likely to be mediating
the effects of DYRK1A.DYRK1B, the closest member to DYRK1A in the DYRK family of pro-
tein kinases (Aranda et al., 2011), also phosphorylates Cyclin D1 at T286
(Ashford et al., 2014) and its overexpression induces cell cycle arrest
(Ashford et al., 2014). Data obtained in transcriptome analysis of differ-
ent cell types of the mouse embryo by deep sequencing shows that the
expression of Dyrk1b in dorsal telencephalic RG progenitors is very low
compared to the expression of Dyrk1a in these cells (Aprea et al., 2013;
GEO GSE51606), indicating that DYRK1A is likely to be the only DYRK
kinase involved in the regulation of Cyclin D1 turnover in cortical RG
progenitors.
During late corticogenesis, by E16.5, Cyclin D1 protein levels in
TgDyrk1a RG progenitors were normal despite the fact that the levels
of DYRK1A in the dorsal telencephalon were still augmented around
50%. Our Cyclin D1 expression data indicates that the levels of Cyclin
D1 in wild-type cortical RG progenitors progressively decrease during
neurogenesis, paralleling the increased duration of G1 phase
(Takahashi et al., 1995). Thus, it is possible that nuclear Cyclin D1 during
late neurogenesis is not regulating progression through G1 and, there-
fore, their levels are not subject to cell cycle regulation.
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the pool size of this type of progenitor is signiﬁcantly diminished in
TgDyrk1a embryos. Consistent with our Cyclin D1 expression data, it has
been shown that cortical IPs do not express Cyclin D1 but instead express
Cyclin D2 (Glickstein et al., 2009). Thus, the early exhaustion of IPs in
TgDyrk1a embryos and the consequent deﬁcit of late-born neurons
observed in this transgenic model at postnatal stages, could be caused
by the dysregulation of a DYRK1A-mediated function other than Cyclin
D1 degradation or could be secondary to the advanced production of
these progenitors. Given that the neurogenic to gliogenic switch in
TgDyrk1aRGprogenitors is also advanced, themost plausible explanation
for the late neurogenic defects observed in TgDyrk1a embryos is that all
the neurogenic program in these embryos is slightly altered due to the
lengthening of the G1 cell cycle phase that occurs at the beginning of
the neurogenic phase of cortical development, which in the short-term
leads to more IPs and less neurons.
Our results show a correlation between the output of RG asymmetric
divisions and the duration of the G1 cell cycle phase in RG progenitors.
This is in line with the accepted idea that the time that a RG progenitor
spends in G1 determines the fate of their daughters (Dehay and
Kennedy, 2007; Gotz and Huttner, 2005; Salomoni and Calegari,
2010); this is supported by experiments showing a signiﬁcant effect
on cortical neurogenesis by shortening the duration of the G1 phase
via forced expression of Cyclin D1 or Cyclin D1/Cdk4 (Lange et al.,
2009; Pilaz et al., 2009). The output of shortening G1 phase duration
in the short-term (24 h–48 h) is a decrease in neuron production and
a concomitant increase in IPs in the VZ and the SVZ, which is the same
effect that we have observed at the beginning of neurogenesis in
TgDyrk1a embryos. Manipulation of the G1 phase in the experiments
reported in Lange et al. (2009) and Pilaz et al. (2009) took place during
mid-corticogenesis (by E13–E14), which implies that the progenitors
are intrinsically different and are exposed to different environmental
cues than progenitors at earlier stages. This could explain why an
increase in G1 phase duration at the beginning of neurogenesis and a
decrease at later stages have similar outputs in the short-term.
In addition to a longer G1 phase, TgDyrk1a apical progenitors had a
longer S phase. It has been reported that the length of the S phase in cor-
tical progenitors is signiﬁcantly shorter in progenitors committed to
produce neurons than in those undergoing self-expanding divisions
(Arai et al., 2011). Therefore, the lengthening of S phase in TgDyrk1a
RG progenitors could be secondary to the increased number of RG
asymmetric proliferative divisions producing IPs due to the action of
DYRK1A on G1. The fact that expanding progenitors spend more time
in S phase than those producing neurons has been interpreted as a
need of these progenitors to guarantee high ﬁdelity DNA replication
and repair (Arai et al., 2011). In the early stages of neural system devel-
opment, the repair of DNA double-strand breaks in proliferating cells
occurs via homologous recombination (Orii et al., 2006). In addition to
its Cdk-associated activity, nuclear Cyclin D1 promotes homologous re-
combination by recruiting RAD51 and BRCA2 to the DNA double-strand
breaks (Jirawatnotai et al., 2011). Thus, it is possible that TgDyrk1a
progenitors with limited amounts of Cyclin D1 spend more time in S
phase to complete DNA replication.
DYRK1A regulates the activity of several signalling pathways
(Aranda et al., 2011) including the calcium/calcineurin/NFATc pathway.
In DS this pathway could be inhibited due to a functional interaction of
DYRK1A with RCAN1 (another chromosome 21 gene also known as
DSCR1) on the activity of NFATc transcription factors (Arron et al.,
2006). Recently, it has been reported that moderate overexpression of
DYRK1A and RCAN1 in VZ cells achieved by in utero electroporation
delays neurogenesis in the mouse dorsal telencephalon and that this
effect requires the action of these two proteins on NFATc activity
(Kurabayashi and Sanada, 2013). The phenotype observed here in
TgDyrk1a embryos indicates that a 1.5-fold increase in DYRK1A protein
levels in cortical progenitors reduces signiﬁcantly the production of
early-born neurons. We have measured the relative levels of Rcan1transcripts and protein isoforms, Rcan1-1 and Rcan1-4 (Davies et al.,
2007), in the telencephalon of TgDyrk1a and wild-type littermate em-
bryos at the onset of neurogenesis. In accordancewith theRcan1 genetic
complement in these embryos we did not ﬁnd differences between
genotypes (Supplementary Fig. 13). As the expression of the Rcan1-4
transcript is induced by calcineurin-NFATc signalling (Yang et al.,
2000), our Rcan1 expression data indicate that NFATc activity is not
signiﬁcantly perturbed in TgDyrk1a progenitors.Rcan1 is in the chromo-
somal region that is triplicated in the Ts65Dn model (Haydar and
Reeves, 2012). Thus, the fact that genetic normalization of Dyrk1a
dosage in trisomic Ts65Dn embryos is sufﬁcient to normalize the
production of early-born cortical neurons in these embryos shows that
Dyrk1a is the only gene in the triplicated region responsible for the
phenotype.
Our results showing that nuclear levels of Cyclin D1 are reduced in
the dorsal telencephalon of Ts65Dn embryos and that genetic normali-
zation of Dyrk1a dosage restores Cyclin D1 to normal levels in the triso-
mic embryos suggests that the action of DYRK1A on Cyclin D1 turnover
contributes to the altered cell cycle parameters observed previously in
the VZ of these embryos (Chakrabarti et al., 2007). These results togeth-
er with the decreased number of neurons and the concomitant increase
in IPs observed here at the onset of cortical neurogenesis in Ts65Dn
embryos indicate that DYRK1A-mediated dysregulation of Cyclin D1
levels in RG progenitors is the cause of the deﬁcit of early-born cortical
neurons and contributes to the expansion of the SVZ observed previous-
ly in the Ts65Dnmodel (Chakrabarti et al., 2007). Based on this, and the
observation that postnatal TgDyrk1a and Ts65Dn mice have a similar
deﬁcit of neurons in their neocortices and that the deﬁcit in both
external and internal cortical neurons in the trisomic Ts65Dn mouse is
restored by normalizing Dyrk1a gene-dosage, we hypothesise that
DYRK1A is contributing to the delayed growth of the cortical wall previ-
ously observed in the Ts65Dn model (Chakrabarti et al., 2007). Future
experiments should aim to conﬁrm this hypothesis.
Cell cycle defects (Contestabile et al., 2007) and a deﬁcit of neurons
(Larsen et al., 2008; Schmidt-Sidor et al., 1990) have been observed in
the cerebral cortex of DS foetuses. Given that ﬁbroblast cells from DS
individuals have less Cyclin D1 and enlarged G1 phases due to the over-
expression of DYRK1A (Chen et al., 2013), and that the role of DYRK1A
on brain development and growth is conserved across evolution
(Tejedor and Hammerle, 2011), it is likely that the overexpression of
DYRK1A in DS also increases G1 phase duration in RG progenitors of
the developing neocortex thereby changing their neurogenic potential
and ﬁnal neuronal output.
DYRK1A has been proposed as a therapeutic target to ameliorate the
cognitive deﬁcit associated with DS (Becker and Sippl, 2011); indeed,
treatment with epigallocatechin-gallate, which can inhibit DYRK1A,
has been used successfully in DS mouse models and in a pilot study
with young DS individuals to improve long-term memory (De la Torre
et al., 2014). Our results show that the effect of DYRK1A on Cyclin
D1 turnover in RG progenitors is dosage-dependent and that the
deleterious effect of low levels of nuclear Cyclin D1 on DS cortical
neurogenesis begins at early stages of prenatal development. These
results should inform the design of prenatal therapeutic interven-
tions aimed at counterbalancing the deleterious effect of DYRK1A
triplication on cortical circuitry formation in DS. Finally, since muta-
tions in the human DYRK1A gene in heterozygosity cause primary
microcephaly (Courcet et al., 2012) and autism (O'Roak et al.,
2012), the phenotype observed here in the Dyrk1a+/− mouse
model also provides insights into the aetiology of the neurological
alterations associated with haploinsufﬁcient mutations in the
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